openPR Logo
Press release

Global Intravenous Immunoglobulins Market Trends & Innovations Forecasted till 2022

06-27-2017 09:23 AM CET | Health & Medicine

Press release from: Market Research Hub - Pharmaceutical Industry

MRH

MRH

The requirement of intravenous immunoglobulins for the treatment of autoimmune diseases develops its importance in the medical sector. To learn more about this blood product, Market Research Hub (MRH) has added a new report to its database which discusses about the intravenous immunoglobulins product types and market expanse. The research study is titled as “Global Intravenous Immunoglobulins Market Research Report 2017”, which also highlights that the market for intravenous immunoglobulins would expand at a positive CAGR growth during the period 2016-2022.

Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1139534

Intravenous immunoglobulin (IVIG) is known to be a blood product created from the serum of between 1000 and 15 000 donors per batch. This product is used for the treatment of various autoimmune, idiopathic and infectious diseases. It is important to know that, IVIG is a permitted treatment for graft versus host disease and ITP. Moreover, it is also accepted for use in patients with Guillain-Barré syndrome, Kawasaki disease and polymyositis/dermatomyositis. Currently, the market reach for intravenous immunoglobulin is spread across the world, with regions such as North America, China, Europe, Southeast Asia, Japan and India enjoying the maximum share. Moreover, the top players functioning in this sector include names like CSL Behring, Octapharma, Grifols, Shire, Bayer, ADMA Biologics and Bharat Serum and Vaccines.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Intravenous Immunoglobulins in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Global Intravenous Immunoglobulins market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
CSL Behring
Grifols
Octapharma
Shire
ADMA Biologics
Bayer
Bharat Serum and Vaccines
Biotest
China Biologic Products
Hualan Biological Engineering
Kedrion Biopharma
Sanquin

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Neurology
Hematology
Immunology

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Intravenous Immunoglobulins for each application, including
Hospitals
Drugstore
Others

Browse Full Report with TOC @ http://www.marketresearchhub.com/report/global-intravenous-immunoglobulins-market-research-report-2017-report.html

Table of Content:
Global Intravenous Immunoglobulins Market Research Report 2017
1 Intravenous Immunoglobulins Market Overview
1.1 Product Overview and Scope of Intravenous Immunoglobulins
1.2 Intravenous Immunoglobulins Segment by Type (Product Category)
1.2.1 Global Intravenous Immunoglobulins Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Intravenous Immunoglobulins Production Market Share by Type (Product Category) in 2016
1.2.3 Neurology
1.2.4 Hematology
1.2.5 Immunology
1.3 Global Intravenous Immunoglobulins Segment by Application
1.3.1 Intravenous Immunoglobulins Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Drugstore
1.3.4 Others
1.4 Global Intravenous Immunoglobulins Market by Region (2012-2022)
1.4.1 Global Intravenous Immunoglobulins Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Intravenous Immunoglobulins (2012-2022)
1.5.1 Global Intravenous Immunoglobulins Revenue Status and Outlook (2012-2022)
1.5.2 Global Intravenous Immunoglobulins Capacity, Production Status and Outlook (2012-2022)

Make an Enquiry @ http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1139534

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of Research Reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Read More Industry News @ https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Intravenous Immunoglobulins Market Trends & Innovations Forecasted till 2022 here

News-ID: 596834 • Views:

More Releases from Market Research Hub - Pharmaceutical Industry

Global Enthesopathy Treatment Market Analysis by Type, Application, Top Key Players are-Abbott Laboratories, Eli Lilly, Janssen Biotech, Pfizer, Siemens and Forecast 2019-2025
Global Enthesopathy Treatment Market Analysis by Type, Application, Top Key Play …
The global market status for Enthesopathy Treatment is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global Enthesopathy Treatment Market Size, Status and Forecast 2019-2025”, which tends to deliver in-depth knowledge associated to the Enthesopathy Treatment market for the present and forecasted period until 2025. Furthermore, the report examines the target market based on market size,
Global BioImaging Technologies Market Status, Growth Opportunity, Scope, Key Players:-Hologic, Hitachi, Digirad, FONAR, Covidien, Mindray and Forecast 2019-2025
Global BioImaging Technologies Market Status, Growth Opportunity, Scope, Key Pla …
The market for BioImaging Technologies is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global BioImaging Technologies Market Size, Status and Forecast 2019-2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore,
Global Drugs and Diagnostics for Hematological Disorders Market Report Overview 2019-2025 | Top Players are-Abbot, Pfizer, Mindray, Roche, Biorad, Siemens
Global Drugs and Diagnostics for Hematological Disorders Market Report Overview …
Market Research Hub (MRH) has actively included a new research study titled “Global Drugs and Diagnostics for Hematological Disorders Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period
Global Biosimilar Testing and Development Services Market Report Overview 2019-2025 | Top Players are-Eurofins Scientific, Exova, Source BioScience, Intertek Group, Sigma-Aldrich
Global Biosimilar Testing and Development Services Market Report Overview 2019-2 …
Market Research Hub (MRH) has actively included a new research study titled “Global Biosimilar Testing and Development Services Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until

All 5 Releases


More Releases for Intravenous

Future Outlook of the Soliris Intravenous Market: Soliris Intravenous Trends and …
The global Soliris Intravenous Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 6.8 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/soliris-intravenous-market Soliris Intravenous Market Overview: The Soliris Intravenous Market is experiencing steady growth driven by the increasing prevalence of rare and chronic diseases such as
Global Large Volume Intravenous Solution Market Size by Application, Type, and G …
USA, New Jersey- According to Market Research Intellect, the global Large Volume Intravenous Solution market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The large volume intravenous (IV) solution market is experiencing robust growth, fueled by the increasing prevalence of chronic diseases, rising surgical procedures, and
Intravenous Iron Drugs Market
The "Intravenous Iron Drugs Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Intravenous Iron Drugs Market, 2024-2031 Verified Market Research's most recent report, "Intravenous Iron Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides
Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Key Finding The global Intravenous (IV) Solution market and is expected to reach USD
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market is
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products. Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14075 Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illness